Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mallinckrodt Plc (NYSE:MNK)

45.91
Delayed Data
As of Apr 25
 +1.46 / +3.28%
Today’s Change
41.57
Today|||52-Week Range
85.83
-7.85%
Year-to-Date
No recent news for Mallinckrodt Plc.

Today’s Trading

Previous close44.45
Today’s open44.89
Day’s range44.54 - 46.05
Volume1,329,036
Average volume (3 months)2,024,938
Market cap$4.8B
Dividend yield--
Data as of 04/25/2017

Growth & Valuation

Earnings growth (last year)+78.72%
Earnings growth (this year)--
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+1.01%
P/E ratio25.1
Price/Sales2.30
Price/Book0.93

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...-1.23-1.07%
ALNYAlnylam Pharmaceutic...+1.05+2.09%
OPKOPKO Health Inc+0.25+3.30%
AGNPRAAllergan plc+3.35+0.40%
Data as of 04/25/2017

Financials

Next reporting dateMay 8, 2017
EPS forecast (this quarter)$1.64
Annual revenue (last year)$3.4B
Annual profit (last year)$548.0M
Net profit margin14.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Chesterfield, Derbyshire

Forecasts


Search for Jobs